Clarus was buying when others were selling. They are the institution that was the lead underwriter back in June when they raised $230 Million private placement for Aphria.
They are privy to insider information...they are buying cheap 848,500 net shares invested $15,903,297
| Broker Positions for C:APH Broker #24 from 20180924 to 20181024 |
| Date | Bought | $Val | Ave | Sold | $Val | Ave | Net | Position | $Net | $Position |
|---|---|---|---|---|---|---|---|---|---|---|
| 20180927 | 525,900 | 9,465,114 | 17.998 | 500,000 | 9,000,000 | 18.00 | 25,900 | 25,900 | -465,114 | -465,114 |
| 20181002 | 0 | 5,000 | 80,000 | 16.00 | -5,000 | 20,900 | 80,000 | -385,114 | ||
| 20181005 | 2,500 | 41,592 | 16.637 | 0 | 2,500 | 23,400 | -41,592 | -426,706 | ||
| 20181010 | 145,900 | 2,910,316 | 19.947 | 0 | 145,900 | 169,300 | -2,910,316 | -3,337,022 | ||
| 20181011 | 200,300 | 4,018,742 | 20.064 | 0 | 200,300 | 369,600 | -4,018,742 | -7,355,764 | ||
| 20181016 | 155,600 | 3,185,588 | 20.473 | 0 | 155,600 | 525,200 | -3,185,588 | -10,541,352 | ||
| 20181017 | 125,900 | 2,204,674 | 17.511 | 4,700 | 87,858 | 18.693 | 121,200 | 646,400 | -2,116,816 | -12,658,168 |
| 20181018 | 2,500 | 51,286 | 20.514 | 0 | 2,500 | 648,900 | -51,286 | -12,709,454 | ||
| 20181022 | 97,400 | 1,566,096 | 16.079 | 0 | 97,400 | 746,300 | -1,566,096 | -14,275,550 | ||
| 20181023 | 102,200 | 1,627,747 | 15.927 | 0 | 102,200 | 848,500 | -1,627,747 | -15,903,297 | ||
| TOTAL | 1,358,200 | 25,071,155 | 18.459 | 509,700 | 9,167,858 | 17.987 | 848,500 | -15,903,297 | ||
APHRIA ANNOUNCES $225 MILLION BOUGHT DEAL
Aphria Inc. has entered into an agreement with Clarus Securities Inc., on behalf of a syndicate of underwriters, pursuant to which the underwriters have agreed to purchase, on a bought deal basis, 18,987,400 common shares of the company at a price of $11.85 per common share for aggregate gross proceeds to the company of $225,000,690.
The company has agreed to grant the underwriters an over-allotment option to purchase up to an additional 2,848,110 common shares at the offering price, exercisable in whole or in part at any time for a period ending 30 days from the closing of the offering. In the event the over-allotment option is exercised in full, the aggregate gross proceeds of the offering will be C$258,750,794.
The Offered Shares are issued pursuant to an underwriting agreement dated June 12, 2018 (the ‘‘Underwriting Agreement’’) by and among the Company, Clarus Securities Inc. (‘‘Clarus’’), as lead underwriter, and Canaccord Genuity Corp., Cormark Securities Inc., Haywood Securities Inc. and INFOR Financial Inc. (collectively, the ‘‘Underwriters’’).The Company’s common shares (the ‘‘Common Shares’’) are currently traded on the Toronto Stock Exchange (the ‘‘TSX’’) under the symbol ‘‘APH’’ and on the OTCQB Venture Market in the United States (the ‘‘OTCQB’’) under the symbol ‘‘APHQF’’.
On June 5, 2018, the last trading day prior to the announcement of the Offering, the closing price of the Common Shares on the TSX was $12.16 and the closing price of the Common Shares on the OTCQB was US$9.40. On June 21, 2018, the last trading day before the date of this Prospectus, the closing price of the Common Shares on the TSX was $13.11 per Common Share and the closing price of the Common Shares on the OTCQB was US$9.85.
The TSX has conditionally approved the listing of the Offered Shares to be distributed under this short form prospectus. Listing will be subject to the Company fulfilling all of the requirements of the
TSX. Price: $11.85 per Common Share Price to the Underwriters’
Net Proceeds to Public(1) Fee(2) the Company(3) Per Offered Share .............................. $11.85 $0.5629 $11.2871 Total $225,000,690
Fee $10,687,532.78
Net To Company APH = $214,313,157.22
The Underwriters have been granted an over-allotment option, exercisable, in whole or in part, at the sole discretion of the Underwriters, for a period of 30 days from and including the Closing Date, to purchase up to an additional 2,848,110 Offered Shares (the ‘‘Over-Allotment Shares’’) at the Offering Price to cover the Underwriters’ over-allocation position, if any, and for market stabilization purposes (the ‘‘Over-Allotment Option’’).
If the Over-Allotment Option is exercised in full, the total ‘‘Price to the Public’’, ‘‘Underwriters’ Fee’’ and ‘‘Net Proceeds to the Company’’ will be $258,750,794, $12,290,662.72 and $246,460,131.28, respectively. This Prospectus qualifies the grant of the Over-Allotment Option and the distribution of the Over-Allotment Shares issuable upon exercise of the Over-Allotment Option. A purchaser who acquires Over-Allotment Shares forming part of the Underwriters’ over-allocation position acquires those Over-Allotment Shares under this Prospectus, regardless of whether the over-allocation position is ultimately filled through the exercise of the Over-Allotment Option or secondary market purchases. See ‘‘Plan of Distribution’’. The following table sets out information relating to the Over-Allotment Option:
Posts
